CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-08-16 | Sharp John P VP Finance and CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −7,500 | 9,166 | ||
| 2013-08-16 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion | +14,583 | $9.96 | $145K | 28,227 |
| 2013-08-16 | Berkman Charles S VP, Gen. Counsel & Secretary | Sale | −14,583 | $42.63 | $622K | 13,644 |
| 2013-08-16 | Berkman Charles S VP, Gen. Counsel & Secretary | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −14,583 | 2,083 | ||
| 2013-08-16 | HIGGINS JOHN L President & CEO | Sale | −10,000 | $42.85 | $429K | 110,025 |
| 2013-06-28 | DeSilva Nishan M VP, Corporate Development | Purchase | +169 | $17.36 | $3K | 15,659 |
| 2013-06-28 | FOEHR MATTHEW W EVP and COO | Purchase | +1,059 | $17.36 | $18K | 44,929 |
| 2013-06-28 | Berkman Charles S VP, Gen. Counsel & Secretary | Purchase | +815 | $17.36 | $14K | 13,644 |
| 2013-06-11 | Sabba Stephen L Director | Grant or award | +3,621 | 21,046 | ||
| 2013-06-11 | Sabba Stephen L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +7,335 | 7,335 | ||
| 2013-06-11 | KNOTT DAVID M Director | Grant or award | +4,318 | 63,743 | ||
| 2013-06-11 | KNOTT DAVID M Director | Grant or award · Non-Qualified Stock Option (right to buy) | +7,335 | 7,335 | ||
| 2013-06-11 | Patel Sunil Director | Grant or award | +2,925 | 39,147 | ||
| 2013-06-11 | Patel Sunil Director | Grant or award | +1,393 | 40,540 | ||
| 2013-06-11 | Patel Sunil Director | Grant or award · Non-Qualified Stock Option (right to buy) | +7,335 | $32.30 | $237K | 7,335 |
| 2013-06-11 | LAMATTINA JOHN L Director | Grant or award | +2,925 | 24,460 | ||
| 2013-06-11 | LAMATTINA JOHN L Director | Grant or award | +696 | 25,156 | ||
| 2013-06-11 | LAMATTINA JOHN L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +7,335 | $32.30 | $237K | 7,335 |
| 2013-06-11 | KOZARICH JOHN W Director | Grant or award | +2,925 | 39,873 | ||
| 2013-06-11 | KOZARICH JOHN W Director | Grant or award | +1,393 | 41,266 |
Page 83 of 86 · 1,712 trades